• Celso Darío Ramos, Denise Engelbrecht Zantut Wittmann, Elba Cristina Sá de Camargo Etchebehere, Marcos Antonio Tambascia, Cleide Aparecida Moreira Silva, and Edwaldo Eduardo Camargo.
• Division of Nuclear Medicine, Department of Radiology, School of Medical Sciences, Campinas State University, Campinas, Brazil. cdramos@mn-d.com
• Sao Paulo Med J. 2002 Mar 7; 120 (2): 454845-8.

ContextThyroid uptake and scintigraphy using 99mTc-pertechnetate has proven to be more advantageous than with 131I-iodide, since the images have better quality, the procedure is faster and the patient is submitted to a lower radiation dose.ObjectiveThe purpose of this study was to standardize a simple and fast methodology for performing thyroid uptake and scintigraphy and to determine the normal values for 99mTc- pertechnetate uptake.Type Of StudyProspective, non-randomized.SettingDivision of Nuclear Medicine, Department of Radiology, School of Medical Sciences, Campinas State University.ParticipantsThe study consisted of 47 normal individuals, 30 women and 17 men, with ages ranging from 19 to 61 years (mean of 33 years).ProceduresThe laboratory assessment of thyroid function consisted of serum dosages of ultra-sensitive thyroxin and thyrotrophin. Twenty minutes after an intravenous injection of 10 mCi (370 MBq) of 99mTc-pertechnetate, the images were obtained on a computerized scintillation camera equipped with a low-energy high-resolution parallel hole collimator.ResultsAll the individuals were euthyroid both on clinical and laboratory evaluation. The baseline thyroid 99mTc-pertechnetate uptake ranged from 0.4 to 1.7%. The uptake values obtained in these normal individuals showed that 95% presented a thyroid uptake that ranged from 0.4 to 1.5% of the injected dose.ConclusionThe assessment of thyroid structure and function using 99mTc-pertechnetate is a simple, fast and efficient method, which could easily become a part of the routine studies in nuclear medicine laboratories.

19 keywords...

hide…